Celltrion
068270.KS
#754
Rank
C$37.41 B
Marketcap
$180.65
Share price
0.72%
Change (1 day)
9.46%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: C$37.41 Billion

As of November 2024 Celltrion has a market cap of C$37.41 Billion. This makes Celltrion the world's 754th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Marketcap Change
2024C$37.41 B-15.74%
2023C$44.40 B80.5%
2022C$24.60 B-16.75%
2021C$29.55 B-48.6%
2020C$57.49 B121.09%
2019C$26.00 B-23.13%
2018C$33.83 B4.54%
2017C$32.36 B121.52%
2016C$14.60 B30.3%
2015C$11.21 B166.77%
2014C$4.20 B10.68%
2013C$3.79 B-12.12%
2012C$4.32 B16.34%
2011C$3.71 B7.78%
2010C$3.44 B148.34%
2009C$1.38 B41.49%
2008C$0.98 B5162.02%
2007C$18.63 M

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Celltrion was reported to be:

C$37.44 Billion
by Yahoo Finance info icon info icon
C$37.41 Billion
by CompaniesMarketCap info icon info icon